Table 1.
Baseline demographic and clinical characteristics of group S (successful fast-track protocol) and group F (fast track protocol failure)
| Group S (n = 172) | Group F (n = 35) | ||||
|---|---|---|---|---|---|
| No. | % | No. | % | ||
| Variables | p | ||||
| Age (years) | 79.2 ± 6.1 | 86.5 ± 2.6 | 0.008 | ||
| Male | 88 | 51 | 25 | 71 | 0.04 |
| STS risk score | 8.2 ± 6.8 | 11.4 ± 8.4 | 0.18 | ||
| Log. EuroSCORE | 23.2 ± 9.7 | 25.8 ± 8.3 | 0.46 | ||
| Atrial fibrillation | 50 | 29 | 9 | 27 | 0.26 |
| Diabetes | 34 | 20 | 12 | 35 | 0.11 |
| Arterial Hypertension | 160 | 93 | 29 | 82 | 0.21 |
| Pulmonary Hypertension | 115 | 67 | 26 | 75 | 0.25 |
| Previous stroke | 26 | 15 | 6 | 17 | 0.15 |
| Peripheral vascular disease | 46 | 27 | 14 | 40 | 0.08 |
| COPD | 53 | 31 | 16 | 47 | 0.17 |
| Chronic renal failure | 91 | 53 | 29 | 82 | 0.31 |
| Mean ejection fraction (%) | 47 ± 15 | 31 ± 5 | 0.05 | ||
| Mean pressure gradient (echo; mmHg) | 51 ± 19 | 44 ± 27 | 0.14 | ||
| Aortic valve area (cm) | 0.66 ± 0.22 | 0.72 ± 0.48 | 0.09 | ||
| Previous cardiac surgery | 50 | 29 | 12 | 35 | 0.29 |
| Preop. MV regurgitation (moderate to severe) | 20 | 11 | 12 | 35 | 0.05 |
COPD chronic obstructive pulmonary disease, Chronic renal failure = glomerular filtration rate < 60 ml/min/1.73 m2; EuroSCORE European system for cardiac risk evaluation, Group F fast track protocol failure, Group S successful fast-track protocol, MV mitral valve, STS risk score The Society of Thoracic Surgeons’ risk sore